000 01655 a2200481 4500
005 20250517052729.0
264 0 _c20160913
008 201609s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.01817-15
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCole, Kelli A
245 0 0 _aOutcomes of Aminopenicillin Therapy for Vancomycin-Resistant Enterococcal Urinary Tract Infections.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cDec 2015
300 _a7362-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAmoxicillin
_xtherapeutic use
650 0 4 _aAmpicillin
_xtherapeutic use
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aCohort Studies
650 0 4 _aEnterococcus
_xdrug effects
650 0 4 _aEnterococcus faecium
_xdrug effects
650 0 4 _aFemale
650 0 4 _aGram-Positive Bacterial Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aMiddle Aged
650 0 4 _aRetrospective Studies
650 0 4 _aTreatment Outcome
650 0 4 _aUrinary Tract Infections
_xdrug therapy
650 0 4 _aVancomycin Resistance
_xdrug effects
700 1 _aKenney, Rachel M
700 1 _aPerri, Mary Beth
700 1 _aDumkow, Lisa E
700 1 _aSamuel, Linoj P
700 1 _aZervos, Marcus J
700 1 _aDavis, Susan L
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 59
_gno. 12
_gp. 7362-6
856 4 0 _uhttps://doi.org/10.1128/AAC.01817-15
_zAvailable from publisher's website
999 _c25261341
_d25261341